Latest Oncology Stories
ThermoDox® Continues to Demonstrate Impressive Local Response Rate in Highly Refractory Patients LAWRENCEVILLE, N.J., April 15, 2015 /PRNewswire/ -- Celsion Corporation (NASDAQ:
LUGANO, Switzerland and WOODCLIFF LAKE, N.J., April 15, 2015 /PRNewswire/ -- Helsinn Group and Eisai Inc.
CALGARY, April 15, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc. ("Oncolytics") (TSX:ONC) (NASDAQ:ONCY) today announced that Dr.
DUBLIN, April 14, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/c2rl8f/oncogene) has announced the addition of the "Oncogene Inhibitors
As many as 19% of women received false negatives for cervical cancer when HPV-only tested, finds Quest Diagnostics Health Trends(TM) study published in Cancer Cytopathology of 256,648 women, one of
MADRID, April 14, 2015 /PRNewswire/ -- - Combination of the anticancer drug PM1183 with PARP inhibitors and doxorubicin results in a synergistic
Researchers say this rare radiotherapy method is not likely to improve outcomes for deadly asbestos cancer. Raleigh, NC (PRWEB) April 13, 2015 Doctors
Esten and leukemia survivor daughter Addie to join thousands across the country for Light The Night Walks to raise funds for cancer cures WHITE PLAINS, N.Y., April 13, 2015 /PRNewswire/
Scientists in one of the world’s most mesothelioma-prone countries say their new asbestos disease prediction matrix could improve mesothelioma diagnosis and outcomes. Raleigh,
- Growing in low tufty patches.